Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (7MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-592547
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.59254
Zusammenfassung
A major bottleneck diminishing the therapeutic efficacy of various drugs is that only small proportions of the administered dose reach the site of action. One promising approach to increase the drug amount in the target tissue is the delivery via nanoparticles (NPs) modified with ligands of cell surface receptors for the selective identification of target cells. However, since receptor binding ...